Skip to main content

Table 4 Comparison between iDC and mDC lymph node uptake

From: Evaluation of in vivo labelled dendritic cell migration in cancer patients

Patients DC i/m × 106 Isotope Max uptake (%) *
G.C. (no. 1) i 6 99m Tc-HMPAO 0.22
G.C. (no. 1) i 6.9 99m Tc-HMPAO 0.05
G.L. (no. 2) i 9 99m Tc-HMPAO 0.05
P.A.M. (no. 3) i 6 111 In-Oxine 0.42
T.N. (no. 5) m 5.6 99m Tc-HMPAO 1.75
P.I.M. (no. 4) m 12 99m Tc-HMPAO 0.53
PA.M. (no. 3) m 7 111 In-Oxine 3.14
S.G. (no. 6) m 6.4 99m Tc-HMPAO 0.39
S.G. (no. 6) m 6.7 111 In-Oxine 1.88
R.L. (no. 7) m 4 99m Tc-HMPAO 0.95
G.D. (no. 8) m 4 99m Tc-HMPAO 1.02
  1. UPTAKE RATIO: mDC/iDC 111In-Oxine average: 6 (range 4–7) 99m Tc-HMPAO average: 8.4 (range 2–35) *Maximum uptake = maximum lymph node activity/ inoculation site activity at 0 h